Cabaletta Bio Inc

General ticker "CABA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $142.9M

Cabaletta Bio Inc does not follow the US Stock Market performance with the rate: -31.6%.

Estimated limits based on current volatility of 4.3%: low 2.24$, high 2.44$

Factors to consider:

  • Current price 78.8% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [11.12$, 23.34$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.89$, 15.98$]

Financial Metrics affecting the CABA estimates:

  • Negative: Non-GAAP EPS, $ of -1.65 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -6.67 <= 2.35
  • Negative: negative Net income
  • Positive: -0.96 < Investing cash flow per share, $ of -0.55
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term CABA quotes

Long-term CABA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $46.31MM $54.14MM $74.66MM
Operating Income $-46.31MM $-54.14MM $-74.66MM
Non-Operating Income $0.02MM $1.16MM $6.99MM
R&D Expense $32.49MM $39.30MM $55.42MM
Income(Loss) $-46.29MM $-52.98MM $-67.67MM
Profit(Loss) $-46.29MM $-52.98MM $-67.67MM
Stockholders Equity $117.96MM $104.52MM $236.20MM
Assets $126.34MM $116.97MM $253.65MM
Operating Cash Flow $-34.11MM $-46.38MM $-53.55MM
Capital expenditure $1.17MM $2.45MM $0.69MM
Investing Cash Flow $6.00MM $-27.22MM $-22.45MM
Financing Cash Flow $48.90MM $32.98MM $187.63MM
Earnings Per Share* $-1.77 $-1.77 $-1.65

* EPS are Split Adjusted, recent splits may be reflected with a delay.